Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fluad
Vaccines
Novavax's NanoFlu bests Sanofi's Fluzone HD in seniors
Novavax's NanoFlu vaccine beat Sanofi's Fluzone HD in seniors in a midstage test, setting up the smaller company's shot for a move into phase 3.
Eric Sagonowsky
Jan 9, 2019 9:26am
Seqirus to spend $140M in N.C. flu vaccine plant expansion
Nov 19, 2018 5:00pm
Officials deny shortage of Seqirus' Fluad in the U.K.
Oct 17, 2018 11:00am
GSK, Seqirus begin shipping flu vaccines for the 2018-19 season
Aug 14, 2018 11:49am
Cell-based flu shots offer slight advantage for seniors: report
Jun 27, 2018 9:10am
U.K. officials prep switch to Seqirus' Fluad in over-75s
Jan 3, 2018 7:14am
